Testing effectiveness (Phase 2)Study completedNCT05960097
What this trial is testing
A Study on the Safety and Immune Response of Investigational COVID-19 mRNA Vaccines in Healthy Adults
Who this might be right for
SARS-CoV-2COVID-19
GlaxoSmithKline 692